| アブストラクト | Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problems.(1) While current models of pharmacovigilance, with their tools and methodologies, were developed for prescription drugs, safety surveillance is just as important for over-the-counter health products such as dietary supplements. The practice of pharmacovigilance is challenging in itself; however, there are unique challenges associated with dietary supplements.(2). |
|---|
| ジャーナル名 | Clinical pharmacology and therapeutics |
|---|
| Pubmed追加日 | 2018/8/18 |
|---|
| 投稿者 | Jordan, Scott A; Jack, Stephanie A; Pless, Robert P |
|---|
| 組織名 | Marketed Biologicals, Biotechnology and Natural Health Products Bureau, Marketed;Health Products Directorate, Health Canada, Ottawa, Ontario, Canada. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/30117148/ |
|---|
